Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|April 2, 2004
Interval-censored survival time data: confidence intervals for the non-parametric survivor functionRuth L Goodall, David T Dunn, Abdel G Babiker
The Pediatric Infectious Disease Journal|January 25, 2003
Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trialDiana M Gibb, Ruth L Goodall, Vania Giacomet, et al.
Antiviral Therapy|May 17, 2007
A virological benefit from an induction/maintenance strategy: the Forte trialDavid Asboe, Ian G Williams, Ruth L Goodall, et al.
Trials|June 7, 2022
Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosisRuth L Goodall, Karen Sanders, Gay Bronson, et al.
Tropical Medicine and Infectious Disease|September 27, 2024
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary AnalysisStella M Fabiane, Chen-Yuan Chiang, Sarah K Meredith, et al.
Expert Opinion on Drug Safety|March 11, 2024
T-wave morphology abnormalities in the STREAM stage 1 trialGareth Hughes, William J Young, Henry Bern, et al.
PLOS Global Public Health|February 10, 2026
QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trialGareth Hughes, Elena Frangou, Henry Bern, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2013
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapyRavindra K Gupta, Ruth L Goodall, Michael Ranopa, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1Adele L McCormick, Chris M Parry, Anne Crombe, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2017
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan AfricaRuth L Goodall, David T Dunn, Peter Nkurunziza, et al.
Pageof 3